European IPO pipeline retains tech focus as Covid variants spread

Sam Kerr

July 12, 2021 03:30 PM

2G5RND2 Beaconsfield, Buckinghamshire, UK. 29th June, 2021. Free NHS Covid-19 lateral flow test packs were being given out to members of the public today in Beaconsfield. A mobile Covid-19 testing service was also available. The Covid-19 restrictions are now expected to be lifted in England from 19th July despite the alarming surge in the number of positive Covid-19 cases due to the Delta Variant. Credit: Maureen McLean/Alamy | Alamy Stock Photo

European IPO bankers have renewed their focus on bringing growth-orientated technology companies to market in the autumn, rather than cyclical firms, as fears over the continuing spread of Covid-19 leading to a fresh wave of lockdowns at the end of the year persist.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Health and Biotech LevFin Equity Europe Private Equity EMEA SRI

SK

Sam Kerr